Septicemia Clinical Trial
Official title:
A Matched, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination When Compared to Laboratory Standard Procedures
Verified date | August 2017 |
Source | Magnolia Medical Technologies, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a matched, open label study to evaluate the Initial Specimen Diversion Device (ISDD) in reducing the contamination rate in blood culture analysis. Blood culture data will be derived from inpatient and/or outpatient settings in a variety of hospital departments (e.g. ER, surgical, medical, etc.). Only samples that are collected via peripheral venipuncture may be included in this study. The ISDD will be compared to current laboratory practices for the collection of blood for culture purposes. Laboratory Standard Procedures (LSP) is defined as collection of venipuncture blood for culture without an initial diversion method to divert and sequester potential blood contaminants.
Status | Completed |
Enrollment | 971 |
Est. completion date | October 2015 |
Est. primary completion date | October 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: - Adults >19 years old Exclusion Criteria: - Not a good candidate for direct-to-media (DTM) technique |
Country | Name | City | State |
---|---|---|---|
United States | University of Nebraska Medical Center | Omaha | Nebraska |
Lead Sponsor | Collaborator |
---|---|
Magnolia Medical Technologies, Inc. |
United States,
Rupp ME, Cavalieri RJ, Marolf C, Lyden E. Reduction in Blood Culture Contamination Through Use of Initial Specimen Diversion Device. Clin Infect Dis. 2017 Apr 3. doi: 10.1093/cid/cix304. [Epub ahead of print] — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of blood culture contamination when using the Initial Specimen Diversion Device (ISDD) compared to Laboratory Standard Procedures (LSP) | Comparison of contamination for each clinical episode. The proportions of discordant contamination episodes will be compared between the Initial Specimen Diversion Device and Lab Standard Practice using McNemar's test. | Baseline | |
Secondary | Occurrence rate of adverse device effects | As the device under study enhances the blood diversion procedure during blood culture collection, and is part of standard blood collection standards, adverse device effects are not expected as a result of use of this device, but shall be recorded consistent with the adverse event definitions found in 21 CFR 812. As this is a commercially available device, medical device reporting shall be performed in accordance with 21 CFR 803, as applicable. | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04764058 -
Efficacy and Safety of Colistin Based Antibiotic Therapy
|
Phase 1/Phase 2 | |
Completed |
NCT03088865 -
Evaluation of an Internal Hospital Practice: The Effect of Altered Test Tubes Sampling Order on Blood Culture Contamination Rates
|
N/A | |
Completed |
NCT00046072 -
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
|
Phase 2 | |
Completed |
NCT01520597 -
National Study on Listeriosis and Listeria
|
||
Recruiting |
NCT03929159 -
Correlating MicroRNA Changes With Sepsis Outcomes
|
||
Completed |
NCT03943719 -
Clinical Impact of the FilmArray Blood Culture Identification Panel Performed on Positive Blood Cultures From Intensive Care Patients With Septicemia
|
||
Completed |
NCT00901940 -
Understanding the Immune Response to Meningitis Vaccines
|
Phase 3 | |
Not yet recruiting |
NCT03583762 -
Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique
|
N/A | |
Completed |
NCT02988414 -
Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
|
||
Recruiting |
NCT05045963 -
Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
|
||
Terminated |
NCT02093494 -
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
|
N/A | |
Active, not recruiting |
NCT02069028 -
Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis
|
N/A | |
Recruiting |
NCT00258869 -
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
|
N/A | |
Completed |
NCT05358912 -
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
|
Phase 4 | |
Recruiting |
NCT05893420 -
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
|
N/A | |
Recruiting |
NCT05040503 -
Monitoring Mitophagy In Myeloid Cells Upon Intensive Care
|
N/A | |
No longer available |
NCT04636554 -
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
|
||
Completed |
NCT00146432 -
Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)
|
Phase 2/Phase 3 |